Collectively, these patient-derived data are in agreement with USP22 deletion and diminished expression being pathogenic events driving cancer progression via aberrant H2Bub1 regulation and CIN in multiple cancer types. Here, USP22 is linked to cervical squamous intraepithelial neoplasia.